false false 0001023994 false --12-31 Q1 2021 Non-accelerated Filer true NASDAQ DE true false 10-Q 0 0 Construction fee of $300,000 with no cost of revenue during 2020. 0001023994 2020-08-19 2020-08-27 0001023994 2019-10-01 2019-12-31 0001023994 2020-09-17 0001023994 2020-05-01 2020-05-15 0001023994 2020-05-15 0001023994 sgbx:ArmstrongMember 2020-09-01 2020-09-23 0001023994 sgbx:ArmstrongMember 2020-09-16 2020-09-23 0001023994 sgbx:SheeranMember 2020-09-16 2020-09-23 0001023994 sgbx:SheeranMember 2020-09-23 0001023994 us-gaap:VehiclesMember 2021-01-01 2021-03-31 0001023994 us-gaap:ConstructionInProgressMember 2020-12-31 0001023994 sgbx:BuildingHeldForLeasesMember 2020-12-31 0001023994 us-gaap:AutomobilesMember 2020-12-31 0001023994 us-gaap:MachineryAndEquipmentMember 2020-12-31 0001023994 sgbx:StockBasedOptionMember 2021-01-01 2021-03-31 0001023994 us-gaap:IPOMember 2020-05-31 0001023994 us-gaap:IPOMember 2020-04-30 0001023994 us-gaap:NotesReceivableMember 2020-04-01 2020-04-30 0001023994 sgbx:CompanyNoteMember 2020-04-01 2020-04-30 0001023994 sgbx:CompanyNoteMember 2020-04-30 0001023994 us-gaap:SupplierConcentrationRiskMember 2020-01-01 2020-03-31 0001023994 sgbx:WarrantFourMember 2017-06-30 0001023994 sgbx:WarrantFourMember 2017-06-01 2017-06-30 0001023994 sgbx:FurnitureAndOtherEquipmentMember 2020-12-31 0001023994 us-gaap:ComputerEquipmentMember 2020-12-31 0001023994 sgbx:OtherReceivableMember 2020-12-31 0001023994 sgbx:RetainageReceivableMember 2020-12-31 0001023994 sgbx:BilledEngineeringServicesMember 2020-12-31 0001023994 sgbx:ConstructionRevenueMember 2020-12-31 0001023994 us-gaap:RetainedEarningsMember 2020-12-31 0001023994 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001023994 us-gaap:CommonStockMember 2020-12-31 0001023994 sgbx:SalesRevenueGoodNetMember 2020-01-01 2020-03-31 0001023994 us-gaap:VehiclesMember srt:MaximumMember 2021-01-01 2021-03-31 0001023994 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2021-01-01 2021-03-31 0001023994 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2021-01-01 2021-03-31 0001023994 us-gaap:BuildingMember srt:MinimumMember 2021-01-01 2021-03-31 0001023994 sgbx:GalvinNoteMember us-gaap:NotesReceivableMember 2020-01-21 0001023994 sgbx:CompanyNoteMember us-gaap:NotesReceivableMember 2020-01-21 0001023994 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-03-31 0001023994 sgbx:NonEmployeesMember 2020-01-01 2020-03-31 0001023994 sgbx:NonDirectorsMember 2020-01-01 2020-03-31 0001023994 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001023994 us-gaap:CommonStockMember 2020-03-31 0001023994 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001023994 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001023994 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001023994 us-gaap:RetainedEarningsMember 2020-03-31 0001023994 us-gaap:AccountsReceivableMember 2020-01-01 2020-03-31 0001023994 us-gaap:CostOfGoodsTotalMember 2020-01-01 2020-03-31 0001023994 sgbx:TwoThousandSixteenPlanMember 2016-10-01 2016-10-26 0001023994 2021-01-01 2021-03-31 0001023994 2020-09-30 0001023994 us-gaap:ConstructionMember 2020-01-01 2020-03-31 0001023994 sgbx:EngineeringServicesMember 2020-01-01 2020-03-31 0001023994 2020-04-30 0001023994 2020-05-01 2020-05-30 0001023994 2020-04-01 2020-04-30 0001023994 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0001023994 us-gaap:NoncontrollingInterestMember 2020-03-31 0001023994 us-gaap:ParentMember 2020-01-01 2020-03-31 0001023994 us-gaap:ParentMember 2020-03-31 0001023994 sgbx:MultiFamiliesMember 2020-01-01 2020-03-31 0001023994 sgbx:OfficeMember 2020-01-01 2020-03-31 0001023994 us-gaap:RetailMember 2020-01-01 2020-03-31 0001023994 sgbx:SpecialUseMember 2020-01-01 2020-03-31 0001023994 us-gaap:RestrictedStockMember 2020-01-01 2020-03-31 0001023994 sgbx:PayrollMember sgbx:StockBasedCompensationPlanMember 2020-01-01 2020-03-31 0001023994 sgbx:WarrantOneMember 2019-04-01 2019-04-30 0001023994 sgbx:WarrantOneMember 2019-04-30 0001023994 sgbx:WarrantTwoMember 2019-04-01 2019-04-30 0001023994 sgbx:WarrantTwoMember 2019-04-30 0001023994 sgbx:CompanyNoteMember us-gaap:NotesReceivableMember 2020-01-01 2020-01-21 0001023994 sgbx:GalvinNoteMember us-gaap:NotesReceivableMember 2020-01-01 2020-01-21 0001023994 sgbx:StockBasedCompensationPlanMember 2020-01-01 2020-03-31 0001023994 us-gaap:StockOptionMember 2020-01-01 2020-03-31 0001023994 sgbx:WarrantThreeMember 2019-08-01 2019-08-31 0001023994 sgbx:WarrantThreeMember 2019-08-31 0001023994 us-gaap:NotesReceivableMember 2020-01-01 2020-01-21 0001023994 us-gaap:NotesReceivableMember 2020-01-21 0001023994 us-gaap:AccountsReceivableMember 2020-01-01 2020-12-31 0001023994 2019-02-01 2019-02-26 0001023994 2019-03-22 0001023994 2019-03-01 2019-03-22 0001023994 2020-01-01 2020-03-31 0001023994 sgbx:NonEmployeesMember 2021-01-01 2021-03-31 0001023994 sgbx:NonDirectorsMember 2021-01-01 2021-03-31 0001023994 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-03-31 0001023994 sgbx:SecuritiesPurchaseAgreementMember us-gaap:InvestorMember 2020-02-01 2020-02-04 0001023994 sgbx:SecuritiesPurchaseAgreementMember us-gaap:InvestorMember 2020-02-04 0001023994 sgbx:StockBasedCompensationPlanMember 2021-01-01 2021-03-31 0001023994 2016-10-01 2016-10-26 0001023994 2017-06-01 2017-06-30 0001023994 2020-03-31 0001023994 2020-12-31 0001023994 2020-01-01 2020-12-31 0001023994 2020-02-01 2020-02-05 0001023994 2020-05-07 2020-05-31 0001023994 2020-05-31 0001023994 us-gaap:StockOptionMember 2021-01-01 2021-03-31 0001023994 2020-05-01 2020-05-31 0001023994 us-gaap:RestrictedStockMember 2021-01-01 2021-03-31 0001023994 us-gaap:ConstructionMember 2021-01-01 2021-03-31 0001023994 sgbx:EngineeringServicesMember 2021-01-01 2021-03-31 0001023994 sgbx:MultiFamiliesMember 2021-01-01 2021-03-31 0001023994 sgbx:OfficeMember 2021-01-01 2021-03-31 0001023994 us-gaap:RetailMember 2021-01-01 2021-03-31 0001023994 sgbx:SpecialUseMember 2021-01-01 2021-03-31 0001023994 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001023994 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001023994 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001023994 sgbx:PayrollMember sgbx:StockBasedCompensationPlanMember 2021-01-01 2021-03-31 0001023994 sgbx:SalesRevenueGoodNetMember 2021-01-01 2021-03-31 0001023994 us-gaap:SupplierConcentrationRiskMember 2021-01-01 2021-03-31 0001023994 sgbx:LiquidityMember 2021-01-01 2021-03-31 0001023994 sgbx:ConstructionBacklogMember 2021-01-01 2021-03-31 0001023994 us-gaap:CostOfGoodsTotalMember 2021-01-01 2021-03-31 0001023994 us-gaap:ComputerEquipmentMember srt:MaximumMember 2021-01-01 2021-03-31 0001023994 us-gaap:EquipmentMember srt:MinimumMember 2021-01-01 2021-03-31 0001023994 srt:MaximumMember us-gaap:EquipmentMember 2021-01-01 2021-03-31 0001023994 srt:ChiefExecutiveOfficerMember 2019-03-01 2019-03-22 0001023994 srt:ChiefExecutiveOfficerMember 2019-02-01 2019-02-26 0001023994 us-gaap:ComputerEquipmentMember srt:MinimumMember 2021-01-01 2021-03-31 0001023994 sgbx:OriginalAgreementMember 2021-01-01 2021-03-31 0001023994 sgbx:NonEmployeeDirectorMember 2020-04-01 2020-04-14 0001023994 2019-01-01 2019-01-15 0001023994 sgbx:EmployeeMember 2020-04-01 2020-04-14 0001023994 2021-03-31 0001023994 us-gaap:CommonStockMember 2019-12-31 0001023994 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001023994 us-gaap:RetainedEarningsMember 2019-12-31 0001023994 2019-12-31 0001023994 sgbx:WithinOneYearMember 2021-03-31 0001023994 sgbx:OneToTwoYearMember 2021-03-31 0001023994 sgbx:StockBasedOptionMember 2020-01-01 2020-03-31 0001023994 us-gaap:ComputerEquipmentMember 2021-03-31 0001023994 sgbx:FurnitureAndOtherEquipmentMember 2021-03-31 0001023994 us-gaap:MachineryAndEquipmentMember 2021-03-31 0001023994 us-gaap:AutomobilesMember 2021-03-31 0001023994 sgbx:BuildingHeldForLeasesMember 2021-03-31 0001023994 us-gaap:ConstructionInProgressMember 2021-03-31 0001023994 sgbx:ConstructionRevenueMember 2021-03-31 0001023994 sgbx:BilledEngineeringServicesMember 2021-03-31 0001023994 sgbx:RetainageReceivableMember 2021-03-31 0001023994 sgbx:OtherReceivableMember 2021-03-31 0001023994 us-gaap:SupplierConcentrationRiskMember 2020-03-31 0001023994 sgbx:MedicalMember 2021-03-31 0001023994 sgbx:MedicalMember 2020-12-31 0001023994 us-gaap:LeaseholdImprovementsMember 2021-03-31 0001023994 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001023994 us-gaap:CommonStockMember 2021-03-31 0001023994 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001023994 us-gaap:RetainedEarningsMember 2021-03-31 0001023994 us-gaap:ParentMember 2019-12-31 0001023994 us-gaap:ParentMember 2020-12-31 0001023994 us-gaap:NoncontrollingInterestMember 2019-12-31 0001023994 us-gaap:NoncontrollingInterestMember 2020-12-31 0001023994 us-gaap:ParentMember 2021-01-01 2021-03-31 0001023994 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001023994 us-gaap:ParentMember 2021-03-31 0001023994 us-gaap:NoncontrollingInterestMember 2021-03-31 0001023994 sgbx:MedicalRevenueMember 2021-01-01 2021-03-31 0001023994 sgbx:MedicalRevenueMember 2020-01-01 2020-03-31 0001023994 2019-06-20 2019-06-21 0001023994 sgbx:TetonMember 2019-01-01 2019-01-31 0001023994 sgbx:TetonMember 2018-09-11 2018-09-12 0001023994 sgbx:TetonMember 2020-02-10 2020-02-11 0001023994 2020-01-30 2020-01-31 0001023994 2020-01-31 0001023994 2020-06-15 0001023994 us-gaap:InvestorMember 2020-12-31 0001023994 us-gaap:InvestorMember 2020-01-01 2020-12-31 0001023994 2021-05-12 0001023994 us-gaap:GovernmentContractMember 2021-01-01 2021-03-31 0001023994 us-gaap:GovernmentContractMember 2020-01-01 2020-03-31 0001023994 srt:HotelMember 2021-01-01 2021-03-31 0001023994 srt:HotelMember 2020-01-01 2020-03-31 0001023994 sgbx:MedicalConstructionMember 2021-01-01 2021-03-31 0001023994 sgbx:MedicalConstructionMember 2020-01-01 2020-03-31 0001023994 us-gaap:AccountsReceivableMember 2021-03-31 0001023994 sgbx:ConstructionMaterialsMember 2021-03-31 0001023994 sgbx:MedicalEquipmentMember 2021-03-31 0001023994 us-gaap:BuildingMember srt:MaximumMember 2021-01-01 2021-03-31 0001023994 sgbx:ConstructionMaterialsMember 2020-12-31 0001023994 sgbx:MedicalEquipmentMember 2020-12-31 0001023994 us-gaap:SubsequentEventMember stpr:TX 2021-05-12 0001023994 us-gaap:SubsequentEventMember stpr:TX 2021-04-01 2021-05-12 0001023994 us-gaap:SubsequentEventMember us-gaap:PendingLitigationMember 2021-04-01 2021-05-12 0001023994 sgbx:LaboratoryAndTemporaryUnitsMember 2021-03-31 0001023994 sgbx:LaboratoryAndTemporaryUnitsMember 2020-03-31 0001023994 sgbx:ConstructionAndEngineeringServicesMember 2021-01-01 2021-03-31 0001023994 sgbx:ConstructionAndEngineeringServicesMember 2020-01-01 2020-03-31 0001023994 sgbx:ContractOneMember sgbx:ExclusiveLicenseAgreementMember 2020-10-01 2020-12-31 0001023994 sgbx:ContractTwoMember sgbx:ExclusiveLicenseAgreementMember 2020-10-01 2020-12-31 0001023994 sgbx:ContractThreeMember sgbx:ExclusiveLicenseAgreementMember 2020-10-01 2020-12-31 0001023994 sgbx:ExclusiveLicenseAgreementMember 2021-01-01 2021-03-31 0001023994 sgbx:ExclusiveLicenseAgreementMember 2020-10-01 2020-12-31 xbrli:shares xbrli:pure utr:acre utr:sqft iso4217:USD iso4217:USD xbrli:shares sgbx:Employee sgbx:Vendors sgbx:Customer sgbx:Item sgbx:Consultants


 


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 


For the quarterly period ended March 31, 2021

 

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to ____________ 

 

Commission file number: 001-38037

 

SG BLOCKS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

95-4463937

(State or other jurisdiction of

 

(I.R.S. Employer

incorporation or organization)

 

Identification No.)

 

 

 

17 State Street, 19th Floor, New York, NY

 

10004

(Address of principal executive offices)

 

(Zip Code)


 

(646) 240-4235

(Registrant’s telephone number, including area code) 

 

Securities registered pursuant to Section 12(b) of the Act: 


Title of Each Class
Trading Symbol(s)
Name of Each Exchange on which Registered
Common Stock, par value $0.01 per share 

SGBX

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes      No   


Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes      No   


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.  

 

Large accelerated filer  ☐

Accelerated filer  ☐  

Non-accelerated filer  ☒

Smaller reporting company  


Emerging growth company  


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes   No   






As of May 12, 2021 the issuer had a total of 8,822,489 shares of the registrant’s common stock, $0.01 par value, outstanding. 


 




SG BLOCKS, INC.

FORM 10-​Q

 

TABLE OF CONTENTS​​​

​​


Page

PART I. FINANCIAL INFORMATION
2
ITEM 1. Financial Statements 2

Condensed Consolidated Balance Sheets as of March 31, 2021 (Unaudited) and December 31, 2020 2

Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2021 and 2020 (Unaudited) 3

Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Three Months Ended March 31, 2021 and 2020 (Unaudited)

4

Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2021 and 2020 (Unaudited) 5

Notes to Condensed Consolidated Financial Statements 6
ITEM 2. Management's Discussion and Analysis of Financial Condition and Result of Operations 33
ITEM 3. Quantitative and Qualitative Disclosures About Market Risk 43
ITEM 4. Controls and Procedures 43
PART II. OTHER INFORMATION 
44
ITEM 1. Legal Proceedings 44
ITEM 1A. Risk Factors 44
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds 46
ITEM 3. Defaults Upon Senior Securities 46
ITEM 4. Mine Safety Disclosures 46
ITEM 5. Other Information 46
ITEM 6. Exhibits 47
SIGNATURES

​​​​​​
1


PART I. FINANCIAL INFORMATION


ITEM 1. Financial Statements


SG BLOCKS, INC. AND SUBSIDIARIES


Condensed Consolidated Balance Sheets

  

 

 

March 31,

2021

 

 

December 31,
 
2020

 

 

 

 (Unaudited)

 

 


 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

10,540,290

 

 

$

13,010,356

 

Accounts receivable, net

 

 

3,216,907

 

 

 

2,635,608

 

Contract assets 

 

 

1,902,577

 

 

 

1,303,136

 

Inventories

934,079


778,144

Prepaid expenses and other current assets

 

 

1,250,315

 

 

 

570,775

 

Total current assets

 

 

17,844,168

 

 

 

18,298,019

 

 

 

 

 

 

 

 

 

 

Property, plant and equipment, net

 

 

3,453,914

 

 

 

2,683,014

 

Goodwill

 

 

1,309,330

 

 

 

1,309,330

 

Right-of-use asset

1,585,538


1,537,545
Long-term note receivable

691,884




682,637

Intangible assets, net

 

 

2,220,702

 

 

 

2,218,609

 

Deferred contract costs, net

142,748


152,944

Total Assets

 

$

27,248,284

 

 

$

26,882,098

 

 

 

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable and accrued expenses

 

$

6,024,738

 

 

$

3,961,961

 

Contract liabilities

 

 

1,133,328

 

 

 

1,774,740

 

    Lease liability, current maturities

432,143


326,654
    Due to affiliates

102,410


965,561
    Assumed liability

114,967


200,765
    Other current liabilities

5,000


5,000

Total current liabilities

 

 

7,812,586

 

 

 

7,234,681

 










Lease liability, net of current maturities

1,152,601


1,209,594
Total liabilities


8,965,187


8,444,275









Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Preferred stock, $1.00 par value, 5,405,010 shares authorized; none issued or outstanding 

 

 

 

 

 

 

Common stock, $0.01 par value, 25,000,000 shares authorized; 8,821,289 issued and outstanding as of March 31, 2021 and 8,596,189 issued and outstanding as of December 31, 2020

 

 

88,213

 

 

 

85,962

 

Additional paid-in capital

 

 

41,431,213

 

 

 

40,443,840

 

Accumulated deficit

 

 

(24,310,423

)

 

 

(22,276,546

)
Total SG Blocks, Inc. stockholders’ equity

17,209,003


18,253,256

Non-controlling interest

 

 

1,074,094

 

 

 

184,567

 

Total stockholders’ equity

18,283,097


18,437,823

Total Liabilities and Stockholders’ Equity

 

$

27,248,284

 

 

$

26,882,098

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

2


SG BLOCKS, INC. AND SUBSIDIARIES

 

Condensed Consolidated Statements of Operations

 

For the 

Three Months Ended

March 31,

 

For the 

Three Months Ended

March 31,

 

 

2021

 

2020

 

 

(Unaudited) 

 

(Unaudited) 

 

Revenue:

 

 

 

 

Construction services $ 3,137,715
$ 89,341

Engineering services

 

93,949

 

 

109,415

 

Medical revenue


5,955,963


Total  

 

9,187,627

 

 

198,756

 

 

 

 

 

 

 

 

Cost of revenue:

 

 

 

 

 

 

Construction services

 

4,093,540

 

 

71,911

 

Engineering services

 

9,770

 

 

80,864

 

Medical revenue 
3,876,136


Total  

 

7,979,446

 

 

152,775

 

 

 

 

 

 

 

 

Gross profit 

 

1,208,181

 

 

45,981

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

Payroll and related expenses

 

827,522

 

 

271,808

 

General and administrative expenses

 

1,461,356

 

 

491,314

 

Marketing and business development expense

 

70,627

 

 

32,338

 

Pre-project expenses

 

10,133

 

 

 

Total

 

2,369,638

 

 

795,460

 

 

 

 

 

 

 

 

Operating loss

 

(1,161,457 )

 

(749,479

)

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

Interest expense

 

(363

)

 

(2,811

)

Interest income

 

17,470

 

 

4,863

 

Total

 

17,107

 

2,052

 

 

 

 

 

 

 

Loss before income taxes  

 

(1,144,350

)

 

(747,427

)

Income tax expense   

 

 

 

 

 

 

 

 

 

 

 

Net loss


(1,144,350

)


(747,427

)

 

 

 

 

 

 

 

Add: net income attributable to noncontrolling interests 
889,527


Net loss attributable to common stockholders of SG Blocks, Inc.  $ (2,033,877 ) $ (747,427 )







Net loss per share attributable to SG Blocks, Inc. - basic and diluted:

 

 

 

 

 

 

Basic and diluted

$

(0.23

)

$

(0.64

)

 

 

 

 

 

 

 

Weighted average shares outstanding:

 

 

 

 

 

 

Basic and diluted

 

8,744,469

 

 

1,165,470

 

 



The accompanying notes are an integral part of these condensed consolidated financial statements.

3


SG BLOCKS, INC. AND SUBSIDIARIES 

 

Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited)

 

 

$0.01 Par Value
Common Stock

 


 

Additional
Paid-in

 


   Accumulated

 


SG Blocks Stockholders' 
Noncontrolling

Total
Stockholders’

 

 

 

Shares

 


Amount

 


  Capital

 


 Deficit

 

Equity

Interests

Equity

 

Balance at December 31, 2019

 


1,157,890

 


$

11,579

 


$

21,932,387

 


$

(17,583,817

) $ 4,360,149
$
$ 4,360,149

 

Stock-based compensation 

 


 



 


 

38,764

 


 

 


38,764



38,764

 

Conversion of restricted stock units to common stock

12,672


126


(126 )









Reverse stock split settlement

(38 )




(122 )



(122 )


(122 )

Net loss

 


 



 


 

 


 

(747,427

)
(747,427 )


(747,427 )
Balance at March 31, 2020

1,170,524

$ 11,705

$ 21,970,903

$ (18,331,244 ) $ 3,651,364
$
$ 3,651,364


























Balance at December 31, 2020   

 


8,596,189

 


$

85,962

 


$

40,443,840

 


$

(22,276,546

) $ 18,253,256
$ 184,567
$ 18,437,823

 

Stock-based compensation 







286,186




286,186



286,186

Conversion of warrants to common stock

 


225,100

 



2,251

 


 

701,187


 

 


703,438



703,438

 

Net income (loss)

 


 



 


 

 


 

(2,033,877

)
(2,033,877 )
889,527

(1,144,350 )

Balance at March 31, 2021

 


8,821,289

 


$

88,213

 


$

41,431,213

 


$

(24,310,423

) $ 17,209,003
$ 1,074,094
$
18,283,097


  

The accompanying notes are an integral part of these condensed consolidated financial statements. 


4


SG BLOCKS, INC. AND SUBSIDIARIES 

Condensed Consolidated Statements of Cash Flows

 

 

For the

Three Months Ended
March 31,
2021

 


For the

Three Months Ended

March 31,
2020

 

 

 

(Unaudited)

 


(Unaudited)

 

Cash flows from operating activities:

 

 

 


 

 

Net loss

 

$

(1,144,350

)

$

(747,427

)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 


 

 

 

Depreciation expense

 

 

91,190

 


 

924

 

Amortization of intangible assets

 

 

40,407

 


 

36,280

 

Amortization of deferred license costs

10,196


10,197

Interest income on long-term note receivable

 

 

(9,247

)

 

(4,863

)

Stock-based compensation

 

 

286,186

 


 

38,764

 

Changes in operating assets and liabilities:

 

 

 

 


 

 

 

Accounts receivable

 

 

(581,299

)

 

6,472

Contract assets 

 

 

(599,441

)

 

93,355


Inventories

(155,935 )


Prepaid expenses and other current assets

 

 

(679,540

)

 

(71,440

)
Right of use asset

97,846



Accounts payable and accrued expenses

 

 

2,062,776


 

(357,323

)

Contract liabilities



(641,412

)

 

(31,751

)
     Due to affiliates

(863,151 )


     Lease liability

(97,342 )


Net cash used in operating activities

 

 

(2,183,116

)

 

(1,026,812

)

 

 

 

 

 


 

 

 

Cash flows from investing activities:

 

 

 

 


 

 

 

     Advances in note receivable



(400,000 )
     Purchase of property, plant and equipment

(862,090 )

     Purchase of intangible asset

(42,500 )


     Payment on assumed liability of acquired assets

(85,798 )


Net cash used in investing activities

 

 

(990,388

)

 

(400,000

)

 

 

 

 

 


 

 

 

Cash flows from financing activities:

 

 

 

 


 

 

 

    Proceeds from long-term note payable




200,000
    Proceeds from conversion of warrants to common stock

703,438



    Settlement of common stock from reverse stock split 



(122 )

Net cash provided by financing activities

 

 

703,438

 


 

199,878

 

 

 


 
Net decrease in cash and cash equivalents

(2,470,066 )

(1,226,934 )









Cash and cash equivalents - beginning of period

13,010,356


1,625,671









Cash and cash equivalents - end of period
$ 10,540,290

$ 398,737


The accompanying notes are an integral part of these condensed consolidated financial statements.


5


SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, and 2020 (Unaudited)

 

1.

Description of Business 

 

SG Blocks, Inc. (collectively with its subsidiaries, the “Company,” “we”, “us” or “our”) was previously known as CDSI Holdings, Inc., a Delaware corporation incorporated on December 29, 1993. On November 4, 2011, CDSI Merger Sub, Inc., the Company’s wholly-owned subsidiary, was merged with and into SG Building Blocks, Inc. (“SG Building,” formerly SG Blocks Inc.) (the “Merger”), with SG Building surviving the Merger and becoming a wholly-owned subsidiary of the Company. The Merger was a reverse merger that was accounted for as a recapitalization of SG Building, as SG Building was the accounting acquirer. Accordingly, the historical financial statements presented are the financial statements of SG Building. 

 

The building products developed with our proprietary technology and design and engineering expertise are generally stronger, more durable, environmentally sensitive, and erected in less time than traditional construction methods. The use of the SGBlocks building structure typically provides between four to six points towards the Leadership in Energy and Environmental Design (“LEED”) certification levels, including reduced site disturbance, resource reuse, recycled content, innovation in design and use of local and regional materials. Due to the ability of SGBlocks to satisfy such requirements, we believe the products produced utilizing our technology and expertise is a leader in environmentally sustainable construction.

 

There are three core product offerings that utilize our technology and engineering expertise. The first product offering involves GreenSteel™ modules, which are the structural core and shell of an SGBlocks building. We procure the containers, engineer required openings with structural steel enforcements, paint the SGBlocks and then delivers them on-site, where the customer or a customer’s general contractor will complete the entire finish out and installation. The second product offering involves replicating the process to create the GreenSteel product and, in addition, installing selected materials, finishes and systems (including, but not limited to floors, windows, doors, interior painting, electrical wiring and fixtures, plumbing outlets and bathrooms, roofing system) and delivering SGBlocks pre-fabricated containers to the site for a third party licensed general contractor to complete the final finish out and installation. Finally, the third product offering is the completely fabricated and finished SGBlocks building (including but not limited to floors, windows, doors, interior painting, electrical wiring and fixtures, plumbing outlets and bathrooms, roofing systems), including erecting the final unit on site and completing any other final steps. The building is ready for occupancy and/or use as soon as installation is completed. Construction administration and/or project management services are typically included in our product offerings

 

The Company also provides engineering and project management services related to the use and modification of Modules in construction. 

 

The Company is now focusing on entering into licensing agreements across the Company’s construction opportunity verticals.

 

During 2020, the Company formed, SG Echo, LLC, a wholly owned subsidiary of the Company. SG Echo, LLC was formed to complete the business acquisition as disclosed in Note 9. The Company acquired substantially all the assets of Echo DCL, a Texas limited liability company, except for Echo's real estate holdings for which we obtained a right of first refusal. Echo was a container/modular manufacturer based in Durant, Oklahoma specializing in the design and construction of permanent modular and temporary modular buildings and was one of the Company's key supply chain partners. Echo catered to the military, education, administration facilities, healthcare, government, commercial and residential customers. This acquisition has allowed the Company to expand its reach for the Modules and offer an opportunity to vertically integrate a large portion of our cost of goods sold, as well as increase margins, productivity and efficiency in the areas of design, estimating, manufacturing and delivery and to become the manufacturer of the Company's core container and modular product offerings.  The Company also entered into a joint venture with Clarity Lab Solutions LLC., to provide clinical lab testing related to COVID-19.

 

As of January 2021, the Company’s condensed consolidated financial statements include the accounts of Chicago Airport Testing LLC (“CAT”). The Company has a variable interest in CAT as described further below. CAT is in the business of marketing, selling, distributing leasing and otherwise commercially exploiting certain products and services in the COVID-19 testing and other medical industry.

 

In addition, during 2021, the Company formed SGB Development Corp. (“SGB Development”), which is wholly-owned by the Company. SGB Development was formed with the purpose of real property development utilizing our technologies.

 

Reverse Stock Split

 

On February 5, 2020, the Company effected a 1-for-20 reverse stock split of its then-outstanding common stock, which has since been converted. All share and per share amounts set forth in the condensed consolidated financial statements of the Company have been retroactively restated to reflect the 1-for-20 reverse stock split as if it had occurred as of the earliest period presented and unless otherwise stated, all other share and per share amounts for all periods presented in these condensed consolidated financial statements have been adjusted to reflect the reverse stock split effected in February 2020.

 

As of March 31, 2021, the Company had 8,821,289 shares of common stock issued and outstanding.

 

6


SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)

 

2.

Liquidity 


As of March 31, 2021, the Company had cash and cash equivalents of $10,540,290 and a backlog of approximately $22.9 million. See Note 12 for a discussion of construction backlog. Based on our conversations with key customers, the Company anticipates its backlog to convert to revenue over the following period: 



   
2021


Within 1 year
$ 10,015,230

1 to 2 years


12,856,250

Total Backlog
$ 22,871,480


The Company has incurred losses since its inception and has negative operating cash flows. Management has taken several actions to ensure that the Company will continue as a going concern. As described below, the Company has recently been able to raise substantial cash through equity offerings. In addition, as further described in these consolidated financial statements, the Company has begun to recognize revenue from new revenue streams. Management believes that these actions will enable the Company to continue as a going concern.


The Company completed a public offering in April and May 2020, which resulted in net proceeds of approximately $1,522,339, and $15,596,141, respectively. See Note 13 for a discussion on these public offerings. The Company believes that it has adequate cash balances to meet obligations coming due in the next twelve months and further intends to meet its capital needs from revenue generated from operations and by containing costs, entering into strategic alliances, as well as exploring other options, including the possibility of raising additional debt or equity capital as necessary. There is, however, no assurance the Company will be successful in meeting its capital requirements prior to becoming cash flow positive.  The Company does not have any additional sources secured for future funding, and if it is unable to raise the necessary capital at the times it requires such funding, it may need to materially change its business plan, including delaying implementation of aspects of such business plan or curtailing or abandoning such business plan altogether.   


With the global spread of the ongoing novel coronavirus ("COVID-19") pandemic during 2020 the Company has implemented business continuity plans designed to address and mitigate the impact of the COVID-19 pandemic on its employees and business. The Company is experiencing delays in projects due to the COVID-19. Any quarantines, the timing and length of containment and eradication solutions, travel restrictions, absenteeism by infected workers, labor shortages or other disruptions to the Company's suppliers and contract manufacturers or customers would likely adversely impact the Company's sales and operating results and result in further project delays. In addition, the pandemic could result in an economic downturn that could affect the demand for the Company's products. Order lead times could be extended or delayed and pricing could increase. Some products or services may become unavailable if the regional or global spread were significant enough to prevent alternative sourcing. Accordingly, the Company is considering alternative product sourcing in the event that product supply becomes problematic. The Company expects this global pandemic to have an impact on the Company's revenue and results of operations, the size and duration of which the Company is currently unable to predict. In addition, to the extent the ongoing COVID-19 pandemic adversely affects the Company's business and results of operations, it may also have the effect of heightening many of the other risks and uncertainties which the Company faces.


7


SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)

  

3.

Summary of Significant Accounting Policies

 

Basis of presentation and principals of consolidation – The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and with the instructions to the Current Report on Form 10-Q and Article 8 Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for annual financial statements. The condensed financial statements and notes should be read in conjunction with the consolidated financial statements and notes for the year ended December 31, 2020 included in the Company's Annual Report on Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on April 15, 2021. In the opinion of management, all adjustments, consisting of normal accruals, considered necessary for a fair presentation of the interim financial statements have been included. Results for the three months ended March 31, 2021 are not necessarily indicative of the results that may be expected for the year ending December 31, 2021.

   

Recently adopted accounting pronouncements - New accounting pronouncements implemented by the Company are discussed below or in the related notes, where appropriate.

 

Accounting estimates – The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Significant areas that require the Company to make estimates include revenue recognition, stock-based compensation, stock warrants liabilities and allowance for credit losses. Actual results could differ from those estimates.


Operating cycle – The length of the Company’s contracts varies, but is typically between six to twelve months.  In some instances, the length of the contract may exceed twelve months. Assets and liabilities relating to contracts are included in current assets and current liabilities, respectively, in the accompanying balance sheets as they will be liquidated in the normal course of contract completion, which at times could exceed one year.


8


SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)

 

3.

Summary of Significant Accounting Policies (continued)


Revenue recognition – The Company determines, at contract inception, whether it will transfer control of a promised good or service over time or at a point in time, regardless of the length of contract or other factors. The recognition of revenue aligns with the timing of when promised goods or services are transferred to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To achieve this core principle, the Company applies the following five steps in accordance with its revenue policy:


                (1)  Identify the contract with a customer

 

                (2)  Identify the performance obligations in the contract

 

                (3)  Determine the transaction price

 

                (4)  Allocate the transaction price to performance obligations in the contract

 

                (5)  Recognize revenue as performance obligations are satisfied


On certain contracts, the Company applies recognition of revenue over time, which is similar to the method the Company applied under previous guidance (i.e. percentage of completion). Due to uncertainties inherent in the estimation process, it is possible that estimates of costs to complete a performance obligation will be revised in the near-term. For those performance obligations for which revenue is recognized using a cost-to-cost input method, changes in total estimated costs, and related progress toward complete satisfaction of the performance obligation, are recognized on a cumulative catch-up basis in the period in which the revisions to the estimates are made. When the current estimate of total costs for a performance obligation indicate a loss, a provision for the entire estimated loss on the unsatisfied performance obligation is made in the period in which the loss becomes evident. 


For product or equipment sales, the Company applies recognition of revenue when the customer obtains control over such goods, which is at a point in time.


On October 3, 2019, the Company entered into an Exclusive License Agreement (“ELA” ) pursuant to which it granted an exclusive license for its technology as outlined in the ELA. The ELA is described below. Under the ELA, the Company will receive royalty payments based upon gross revenues earned by the licensee for commercialized products within the field of design and project management platforms for residential use, including single-family residences and multi-family residences, but excluding military housing. The Company has determined that the ELA grants the licensee a right to access the Company’s intellectual property throughout the license period (or its remaining economic life, if shorter), and thus recognizes revenue over time as the licensee recognizes revenue and the Company has the right to payment of royalties. No revenue has been recognized under the ELA for the three months ended March 31, 2021.  


CMC Right of First Refusal Agreement – On October 9, 2019, the Company entered into a Right of First Refusal Agreement (the “Agreement”) with CMC Development LLC (“CMC”), which has a term of two (2) years. Under the Agreement, the Company has a right of first refusal with respect to being engaged as a designer and builder of any real estate projects for which CMC has secured the rights to develop and in which CMC has a greater than fifty percent (50%) interest in the owner or developer entity and has the right to select the builder for such real estate project (the “ROFR Rights”). In exchange for such ROFR Rights, the Company agreed to issue to CMC 2,500 shares of restricted stock of the Company’s common stock, of which 1,250 shares vested on March 31, 2021 and the remaining 1,250 shares will vest and be issued on September 30, 2021, unless the Agreement is earlier terminated. In the event that the Agreement is earlier terminated, CMC will still be entitled to receive the entire amount of such restricted stock that has vested as of such earlier termination date, but in no event less than 1,250 shares of such restricted stock. The Agreement also provides for customary indemnification and confidentiality obligations between the parties. The 2,500 shares of restricted stock of the Company's common stock has yet to be issued to CMC. 

 

The Agreement also provides that CMC has engaged the Company to build and design, in the aggregate, approximately 100 residential and commercial units at 1100 Ridge Avenue, Atlanta, Georgia, which is known as the “Ridge Avenue, Atlanta Project.” The total value of the project estimated to be derived by CMC is approximately $16,900,000. The project is a residential project but not subject to the Company’s Exclusive License Agreement, dated October 3, 2019. 


9


SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)

 

3.

Summary of Significant Accounting Policies (continued)



The Company entered into a joint venture agreement with Clarity Lab Solutions, LLC (“Clarity Labs”) (the “JV”) in the fourth quarter of 2020. Revenue from the activities of the JV is related to clinical testing services and is recognized when services have been rendered, which is at a point in time.  Included in the consideration the Company expected to be entitled to receive, the Company estimates its contractual allowances, payer denials and price concessions. During the three months ended March 31, 2021, the Company recognized $5,863,358 related to activities through the JV, is included in medical revenue on the accompanying consolidated statements of operations. In addition, the Company formed Chicago Airport Testing, LLC which is currently collecting rental revenue from subleasing to a consortium of government entities assisting in COVID-19 testing.


Disaggregation of Revenues


The Company’s revenues are principally derived from construction and engineering contracts related to Modules, and medical revenue derived from lab testing and test kit sales. The Company's contracts are with customers in various industries. Revenue recognized at a point in time and recognized over time were $5,965,413 and $3,222,214, respectively, for the three months ending March 31, 2021. All revenue recognized for the three months ending March 31, 2020 was over time.

 

The following tables provide further disaggregation of the Company’s revenues by categories:   




Three Months Ended March 31,

Revenue by Customer Type

2021

2020


Construction and Engineering Services:














   Government
$ 1,085,480

12 %
$
%

   Hotel

170,426

2 %



%

   Medical - Construction

251,560

3

%


%


   Multi-Family (includes Single Family)

44,746

%

30,672

15 %

   Office

177,392

1

%


40,850

21

%

   Retail


42,015

1

%

121,070

61

%


   Special Use

1,460,045

16 %

6,164

3 %

Subtotal

3,231,664

35 %

198,756

100

Medical Revenue:














   Medical (lab testing, kit sales and equipment)

5,955,963

65 %





Total revenue by customer type  

$

9,187,627

100


$

198,756

100


10


SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)

 

3.

Summary of Significant Accounting Policies (continued)

 

Contract Assets and Contract Liabilities

Accounts receivable are recognized in the period when the Company’s right to consideration is unconditional. Accounts receivable are recognized net of an allowance for credit losses. A considerable amount of judgment is required in assessing the likelihood of realization of receivables.

The timing of revenue recognition may differ from the timing of invoicing to customers. 

Contract assets include unbilled amounts from long-term construction services when revenue recognized under the cost-to-cost measure of progress exceeds the amounts invoiced to customers, as the amounts cannot be billed under the terms of our contracts. Such amounts are recoverable from customers based upon various measures of performance, including achievement of certain milestones, completion of specified units or completion of a contract. Contract assets are generally classified as current within the condensed consolidated balance sheets. 

 

Contract liabilities from construction and engineering contracts occur when amounts invoiced to customers exceed revenues recognized under the cost-to-cost measure of progress. Contract liabilities additionally include advanced payments from customers on certain contracts. Contract liabilities decrease as the Company recognizes revenue from the satisfaction of the related performance obligation. Contract liabilities are generally classified as current within the condensed consolidated balance sheet. 

 

Although the Company believes it has established adequate procedures for estimating costs to complete on open contracts, it is at least reasonably possible that additional significant costs could occur on contracts prior to completion. The Company periodically evaluates and revises its estimates and makes adjustments when they are considered necessary.


Deferred Contract Costs - Prior to entering into the ELA, the Company was subject to an agreement to construct and develop a certain property (“Original Agreement”), which now is subject to the ELA. Because of this, the Company is no longer obliged to its Original Agreement. Upon entering the ELA, the Company had an outstanding accounts receivable balance of $306,143which was forfeited and recognized this amount as deferred contract costs. This amount was offset by $102,217, which was reimbursement from the licensee for project costs on this project.  The Company incurred total deferred contract costs of $203,926.  The Company considered this amount an incremental cost of obtaining that ELA, because the Company expects to recover those costs through future royalty payments. The Company plans to amortize the asset over sixty months, which is the initial term of the ELA because the asset relates to the services transferred to the customer during the contract term. As of March 31, 2021, accumulated amortization related to deferred contract costs amounted to $61,178. During the three months ended March 31, 2021 and 2020, amortization expense relating to the deferred contract costs amounted to $10,196 and $10,197, respectively, and is included in general and administrative expenses on the accompanying condensed consolidated statement of operations.

 

Exclusive License Agreement – On October 3, 2019, as amended on October 17, 2019, the Company entered into the ELA with CPF GP 2019-1 LLC (the “Licensee”), pursuant to which the Company granted the Licensee an exclusive license (the “License”) solely within the United States and its legal territories to the Company’s technology, intellectual property, any improvements thereto, and any related permits, in order to develop and commercialize products within the field of design and project management platforms for residential use, including single-family residences and multi-family residences, but excluding military housing. The Ridge Avenue Project has also been excluded from the License. The License Agreement has an initial term of five (5) years and will automatically renew for subsequent five (5) year periods. The License Agreement provides for customary terminating provisions, including the right by the Company to terminate if the Licensee fails to make minimum royalty payments (as described below).

  

11


SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)

 

3.

Summary of Significant Accounting Policies (continued)

In consideration for the License, during the initial term, the Licensee agreed to pay the Company a royalty of (x) five percent (5%) on the first $20,000,000 of gross revenues derived from the Licensee’s commercialization of the License (net of customary discounts, sales taxes, delivery charges, and amounts for returns) (the “Gross Revenues”), (y) four and one-half percent (4.5%) on the next $30,000,000 of Gross Revenues, and (z) five percent (5%) on all Gross Revenues thereafter (collectively, the “Royalty”) , subject to the following minimum royalty payments determined on a cumulative basis during the initial term: $500,000 in year 1, $750,000 in year 2, $1,500,000 in year 3, $2,000,000 in year 4, and $2,500,000 in year 5. If the License Agreement is extended beyond the initial term, then the parties will negotiate in good faith the royalty rate and the minimum royalty payments for the renewal term(s). In addition, to the extent the Licensee sublicenses any aspect of the License to a sub-licensee, the Licensee will pay to the Company fifty percent (50%) of all payments received by the Licensee from such sublicensee. The Company may also provide the Licensee with professional services with respect to the License, and the Licensee will reimburse the Company for employees’ time, materials, and expenses incurred in providing such professional services. The Licensee also separately agreed to reimburse the Company for any third-party expenses incurred by the Company in developing the Company’s remaining and future residential projects. As of March 31, 2021, there have been no royalties.

 

The License Agreement provides for customary indemnification obligations between the parties and further provides that the Licensee will indemnify the Company for any claims arising out of the commercialization of the License by the Licensee or any of its subsidiaries, contractors, or sublicensees. In addition, the License Agreement provides that the Company will provide the Licensee with cost estimates for the fabrication and manufacturing of residential projects in the Company’s existing pipeline as of the date of the License Agreement, and if such projects cannot be reasonably constructed and installed at or below such estimates, then the Licensee may withhold payment of any royalty due to the Company under the License Agreement on a dollar-for-dollar basis to offset the costs above the originally estimated amounts.

 

Business Combinations - The Company accounts for business acquisitions using the acquisition method of accounting in accordance with ASC 805 “Business Combinations”, which requires recognition and measurement of all identifiable assets acquired and liabilities assumed at their fair value as of the date control is obtained. The Company determines the fair value of assets acquired and liabilities assumed based upon its best estimates of the acquisition-date fair value of assets acquired and liabilities assumed in the acquisition. Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired. Subsequent adjustments to fair value of any contingent consideration are recorded to the Company’s condensed consolidated statements of operations. Costs that the Company incurs to complete the business combination are charged to general and administrative expenses as they are incurred.

 

Variable Interest Entities – The Company accounts for certain legal entities as variable interest entities (“VIE"). When evaluating a VIE for consolidation, the Company must determine whether or not there is a variable interest in the entity. Variable interests are investments or other interests that absorb portions of an entity’s expected losses or receive portions of the entity’s expected returns. If it is determined that the Company does not have a variable interest in the VIE, no further analysis is required and the VIE is not consolidated. If the Company holds a variable interest in a VIE, the Company consolidates the VIE when there is a controlling financial interest in the VIE and therefore are deemed to be the primary beneficiary. The Company is determined to have a controlling financial interest in a VIE when it has both the power to direct the activities of the VIE that most significantly impact the VIE economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to that VIE. This determination is evaluated periodically as facts and circumstances change.

 

On August 27, 2020 the Company entered into a joint venture agreement with Clarity Lab Solutions, LLC (“Clarity Labs”) (the “JV”).  In consideration and subject to Clarity Lab’s services and commitments and provided the agreement remains valid and in force, and is not terminated, the Company agreed to issue 200,000 restricted shares of SGB common stock over a defined vesting period starting in December 1, 2020. Clarity Labs is a licensed clinical laboratory that uses specialized molecular testing equipment and that focuses on the diagnosis and treatment of critical diseases, including COVID-19. Clarity Labs is also engaged in the business of manufacturing, importing and distributions various medical tests. Under the JV, the Company and Clarity Labs will jointly market, sell, and distributed certain products and services (“Clarity Mobile Venture”).  As of March 31, 2021, $102,410 was due to Clarity Labs for expenses paid on behalf of Clarity Mobile Venture, and is included in Due to Affiliates on the accompanying consolidated balance sheets. In addition, during the three months ended March 31, 2021, the Company recognized revenue of $60,110 to Clarity Labs, of which $140,258 is included in accounts receivable as of March 31, 2021. The Company has determined it is the primary beneficiary of Clarity Mobile Venture and has thus consolidated the activities in its condensed consolidated financial statements.

 

On January 18, 2021 the Company entered into an operating agreement to form CAT. The purpose of CAT is to market, sell, distribute, lease and otherwise commercially exploit certain products and services in the COVID-19 testing industry.  The Company has determined it is the primary beneficiary of CAT and has thus consolidated the activities in its condensed consolidated financial statements.

12


SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)

 

3.

Summary of Significant Accounting Policies (continued)


Cash and cash equivalents – The Company considers cash and cash equivalents to include all short-term, highly liquid investments that are readily convertible to known amounts of cash and have original maturities of three months or less upon acquisition. Cash and cash equivalents totaled $10,540,290 as of March 31, 2021 and $13,010,356 as of December 31, 2020. 

 

Short-term investment – The Company classifies investments consisting of a certificate of deposit with a maturity greater than three months but less than one year as short-term investment.  The Company had no short-term investment as of March 31, 2021 or December 31, 2020, respectively.   

 

Accounts receivable and allowance for credit losses Accounts receivable are receivables generated from sales to customers and progress billings on performance type contracts. Amounts included in accounts receivable are deemed to be collectible within the Company’s operating cycle. The Company recognizes accounts receivable at invoiced amounts. 


The allowance for credit losses reflects the Company's best estimate of expected losses inherent in the accounts receivable balances. Management provides an allowance for credit losses based on the Company’s historical losses, specific customer circumstances, and general economic conditions. Periodically, management reviews accounts receivable and adjusts the allowance based on current circumstances and charges off uncollectible receivables when all attempts to collect have been exhausted and the prospects for recovery are remote. Recoveries are recognized when they are received. Actual collection losses may differ from our estimates and could be material to our condensed consolidated financial position, results of operations, and cash flows. 

 

Inventory – Raw construction materials (primarily shipping containers and fabrication materials) are valued at the lower of cost (first-in, first-out method) or net realizable value. Finished goods and work-in-process inventories are valued at the lower of cost or net realizable value, using the specific identification method. Medical equipment and COVID-19 test and testing supplies are valued at the lower of cost, (first-in, first-out method) or net realizable value. As of March 31, 2021 there was inventory of $4,429 for construction materials, and $929,650 of medical equipment and COVID-19 test and testing supplies. As of December 31, 2020 there was inventory of $4,429 for construction materials, and $773,715 of medical equipment and COVID-19 test and testing supplies. 


Goodwill – The Company performs its impairment test of goodwill at the reporting unit level each fiscal year, or more frequently if events or circumstances change that would more likely than not reduce the fair value of its reporting unit below its carrying values. The Company performs a goodwill impairment test by comparing the fair value of the reporting unit with its carrying value and recognizes an impairment charge for the amount by which the carrying value exceeds the fair value, not to exceed the total amount of goodwill. The amount by which the carrying value of the goodwill exceeds its implied fair value, if any, is recognized as an impairment loss. The Company’s evaluation of goodwill completed during the year ended December 31, 2019 resulted in impairment loss of $2,938,653which represents the total goodwill impairment loss to date. The impairment loss was due to a deterioration in the Company's estimated future cash flows. There were no impairments during the year ended December 31, 2020 or the three months ended March 31, 2021. The Company has taken the recent COVID-19 pandemic into consideration when determining impairment. 


13


SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)


3.

Summary of Significant Accounting Policies (continued)


Intangible assets Intangible assets consist of $2,766,000 of proprietary knowledge and technology, which is being amortized over 20 years. In addition, $97,164 of trademarks, and $47,800 of website costs are being amortized over 5 years.  The Company evaluated intangible assets for impairment during the year ended December 31, 2020, and determined that there were no impairment losses. There was no impairment during the three months ended March 31, 2021. The accumulated amortization as of March 31, 2021 and 2020 was $690,262 and $1,650,595, respectively. The amortization expense for the three months ended March 31, 2021 and 2020 was $40,407 and $36,280, respectively. The estimated amortization expense for the successive five years is as follows:  

  


For the year ending December 31,:

 

 

 


2021 

 

$

125,470

 


2022 

 

 

162,970

 


2023

 

 

161,176

 


2024 

 

 

160,469

 


2025

 

 

157,051

 


Thereafter 

 

 

1,453,566

 


 

 

$

2,220,702

 


Property, plant and equipment – Property, plant and equipment is stated at cost. Depreciation is computed using the straight-line method over the estimated lives of each asset. Estimated useful lives for significant classes of assets are as follows: computer and software 3 to 5 years, furniture and other equipment 5 to 7 years, automobiles 2 to 5 years, buildings held for lease 5 to 7 years, and equipment 5 to 29 years. Repairs and maintenance are charged to expense when incurred.

 

Convertible instruments – The Company bifurcates conversion options from their host instruments and accounts for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.


Common stock purchase warrants and other derivative financial instruments – The Company classifies as equity any contracts that (i) require physical settlement or net-share settlement or (ii) provides a choice of net-cash settlement or settlement in the Company’s own shares (physical settlement or net-share settlement) providing that such contracts are indexed to the Company’s own stock. The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if any event occurs and if that event is outside the Company’s control) or (ii) gives the counterparty a choice of net-cash settlement or settlement shares (physical settlement or net-cash settlement). The Company assesses classification of common stock purchase warrants and other free standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities or equity is required.


14


SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)

 

3.

Summary of Significant Accounting Policies (continued)

 

Fair value measurements – Financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities are carried at cost, which the Company believes approximates fair value due to the short-term nature of these instruments.

 

The Company measures the fair value of financial assets and liabilities based on the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Company maximizes the use of observable inputs and minimizes the use of unobservable inputs when measuring fair value.


The Company uses three levels of inputs that may be used to measure fair value:

 

 

Level 1

Quoted prices in active markets for identical assets or liabilities.

 

Level 2

Quoted prices for similar assets and liabilities in active markets or inputs that are observable.

 

Level 3

Inputs that are unobservable (for example, cash flow modeling inputs based on assumptions).


Transfer into and transfers out of the hierarchy levels are recognized as if they had taken place at the end of the reporting period. 


Share-based payments – The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. For employees and directors, including non-employee directors, the fair value of a stock option award is measured on the grant date. The fair value amount is then recognized over the period services are required to be provided in exchange for the award, usually the vesting period. The Company recognizes stock-based compensation expense on a graded-vesting basis over the requisite service period for each separately vesting tranche of each award. Stock-based compensation expense to employees and all directors are reported within payroll and related expenses in the consolidated statements of operations. Stock-based compensation expense to non-employees is reported within marketing and business development expense in the condensed consolidated statements of operations.   


Income taxes  The Company accounts for income taxes utilizing the asset and liability approach. Under this approach, deferred taxes represent the future tax consequences expected to occur when the reported amounts of assets and liabilities are recovered or paid. The provision for income taxes generally represents income taxes paid or payable for the current year plus the change in deferred taxes during the year. Deferred taxes result from the differences between the financial and tax bases of the Company’s assets and liabilities and are adjusted for changes in tax rates and tax laws when changes are enacted.

 

The calculation of tax liabilities involves dealing with uncertainties in the application of complex tax regulations. The Company recognizes liabilities for anticipated tax audit issues based on the Company’s estimate of whether, and the extent to which, additional taxes will be due. If payment of these amounts ultimately proves to be unnecessary, the reversal of the liabilities would result in tax benefits being recognized in the period when the liabilities are no longer determined to be necessary. If the estimate of tax liabilities proves to be less than the ultimate assessment, a further charge to expense would result.


15


SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)

 

3.

Summary of Significant Accounting Policies (continued)

 

Concentrations of credit risk Financial instruments, that potentially subject the Company to concentration of credit risk, consist principally of cash and cash equivalents. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of the FDIC insurance limits. The Company has not experienced any losses in such account and believes that it is not exposed to any significant credit risk on the account.

 

With respect to receivables, concentrations of credit risk are limited to a few customers in the construction industry. The Company performs ongoing credit evaluations of its customers’ financial condition and, generally, requires no collateral from its customers other than normal lien rights. At March 31, 2021 and December 31, 2020, 84% and 79%, respectively, of the Company’s gross accounts receivable were due from four and three customers. 

 

 Revenue relating to two and four customers represented approximately 80% and 73% of the Company's total revenue for the three months ended March 31, 2021 and 2020, respectively.

 

Cost of revenue relating to two and three vendors represented approximately 28% and 90% of the Company’s total cost of revenue for the three months ended March 31, 2021 and 2020, respectively. The Company believes it has access to alternative suppliers, with limited disruption to the business, should circumstances change with its existing suppliers.


4.

Accounts Receivable

 

At March 31, 2021 and December 31, 2020, the Company’s accounts receivable consisted of the following:



 

 

2021

 

 

2020

 


Billed: 

 

 

 

 

 

 


   Construction services

$ 2,049,179

$ 1,391,555

   Engineering services

 

 

68,223

 

 

 

86,264

 


   Medical revenue

1,098,271


1,157,819

   Retainage receivable

 

 

615,136

 

 

 

615,136

 


   Other receivable


182,012


180,748

      Total gross receivables

 

 

4,012,821

 

 

 

3,431,522

 


Less: allowance for credit losses  

 

 

(795,914

)

 

 

(795,914

)


      Total net receivables  

 

$

3,216,907

 

 

$

2,635,608

 


Receivables are evaluated for collectability and allowances for potential losses are established or maintained on applicable receivables. The allowance of doubtful accounts was $795,914 as of March 31, 2021. There was no provision for doubtful accounts, no recoveries collected for doubtful accounts and no write offs during the three months ended March 31, 2021. There was a provision for doubtful accounts of $10,018, and no write offs for the year ended December 31, 2020.

16


SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)

 

5.

Contract Assets and Contract Liabilities  

 

Costs and estimated earnings on uncompleted contracts, which represent contract assets and contract liabilities, consisted of the following at March 31, 2021 and December 31, 2020:

 

 

 

 

2021

 

 

2020

 

 

Costs incurred on uncompleted contracts 

 

$

6,280,201

 

 

$

4,572,581

 

 

Estimated earnings to date on uncompleted contracts

 

 

(350,587

)  

 

 

872,302

 

 

Gross contract assets

 

 

5,929,614

 

 

 

5,444,883

 

 

Less: billings to date

 

 

(5,160,365

)

 

 

(5,916,487

)

 

    Net contract assets (liabilities), on uncompleted contracts

 

$

769,249

 

$

(471,604

)

             

The above amounts are included in the accompanying condensed consolidated balance sheets under the following captions at March 31, 2021 and December 31, 2020. 


   

 

 

2021

 

 

2020

 

 

Contract assets 

 

$

1,902,577

 

 

$

1,303,136

 

 

Contract liabilities

 

 

(1,133,328

)

 

 

(1,774,740

)

 

    Net contract assets (liabilities)

 

$

769,249

 

$

(471,604

)

 

Although management believes it has established adequate procedures for estimating costs to complete on open contracts, it is at least reasonably possible that additional significant costs could occur on contracts prior to completion. The Company periodically evaluates and revises its estimates and makes adjustments when they are considered necessary. 


6.

Property, plant and equipment

 

Property, plant and equipment are stated at cost less accumulated depreciation and amortization and depreciated using the straight-line method over their useful lives. At March 31, 2021 and December 31, 2020, the Company’s property, plant and equipment, net consisted of the following:

 

 


 

2021

 

 

2020

 

 

Computer equipment and software 

 

$

119,437

 

 

$

73,991

 

 

Furniture and other equipment

 

 

16,286

 

 

 

11,593

 


Leasehold improvements


13,871


6,071

Equipment and machinery

1,155,324


1,127,647

Automobiles

4,638


4,638

Building held for leases

501,336


501,336

Laboratory and temporary units

1,350,197


1,016,238

Construction in progress

442,515



 

      Property, plant and equipment

 

 

3,603,604

 

 

 

2,741,514

 

 

Less: accumulated depreciation

 

 

(149,690

)

 

 

(58,500

)

 

      Property, plant and equipment, net

 

$

3,453,914

 

 

$

2,683,014

 

 

Depreciation expense for the three months ended March 31, 2021 and 2020 amounted to $91,190 and $924 respectively. 


17


SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)

 

7.

Notes Receivable 


On January 21, 2020, CPF GP 2019-1 LLC (“CPF GP”) issued to the Company a promissory note in the principal amount of $400,000 (the “Company Note”) and issued to Paul Galvin, the Company’s Chairman and CEO, a promissory note in the principal amount of $100,000 (the “Galvin Note”). The transaction closed on January 22, 2020, on which date the Company loaned CPF GP 2019-1 LLC $400,000 and Mr. Galvin personally loaned CPF GP $100,000 on behalf of the Company. The Company Note and Galvin Note were issued pursuant to that certain Loan Agreement and Promissory Note, dated October 3, 2019 (the “Loan Agreement”), as amended on October 15, 2019 and November 7, 2019 by and between the CPF GP and the Company, and bear interest at five percent (5%) per annum, payable, together with the unpaid principal amount of the promissory notes, on the earlier of the July 31, 2023 maturity date or upon the liquidation, redemption sale or issuance of a dividend upon the LLC interests in CPF MF 2019-1 LLC, a Texas limited liability company of which CPF GP is the general partner; provided, that the terms of the Galvin Note provide that all interest payments due to Mr. Galvin under the Galvin Note shall be paid directly to, and for the benefit of, the Company. 


In April 2020, CPF GP issued to the Company a promissory note in the principal amount of $250,000 (the “Company Note 2”). The transaction closed on April 15, 2020, on which date the Company loaned CPF GP 2019-1 LLC $250,000. The Company Note was issued pursuant to that certain Loan Agreement and Promissory Note, dated October 3, 2019 (the “Loan Agreement 2”), as amended on October 15, 2019 and November 7, 2019 by and between the CPF GP and the Company, and bear interest at five percent (5%) per annum, payable, together with the unpaid principal amount of the promissory notes, on the earlier of the July 31, 2023 maturity date or upon the liquidation, redemption sale or issuance of a dividend upon the LLC interests in CPF MF 2019-1 LLC, a Texas limited liability company of which CPF GP is the general partner. 


8.

Notes Payable


On February 4, 2020, the Company entered into a Securities Purchase Agreement with an accredited investor, pursuant to which the Company issued to the investor a secured note in the aggregate principal amount of $200,000 (“Note”) that bears interest at a rate of nine percent (9%) per annum, due on July 31, 2023, that is secured under a Pledge Agreement, dated February 4, 2020, entered into with the investor by a security interest in the royalty payable to the Company under that certain Exclusive License Agreement, dated October 3, 2019, with CPF GP 2019-1 LLC. The Company had the right to prepay the Note, in whole or in part, at any time and from time to time, without premium or penalty. During 2020, the Note to investor of $200,000 and unpaid accrued interest of $6,263 was converted into 73,665 shares of the Company's common stock.

18


SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)


9.

Business Combination

 

On September 17, 2020, the Company, through SG Echo, LLC (its wholly owned subsidiary), entered into an Asset Purchase Agreement (“APA") to acquire substantially all of the assets of Echo DCL, LLC (“Echo”) for $1,059,600 in cash (the “Echo Acquisition”), except for ECHO DCL's real estate holdings. The Echo Acquisition closed on September 23, 2020. In addition, the sellers of Echo have the potential of additional consideration based upon the APA.  In accordance with ASC 805, the Echo Acquisition is accounted for as a business combination. The Echo Acquisition was made for the purpose of expanding the Company’s footprint into the modular manufacturing business. 

 

The purchase consideration amounted to:

 


Cash $ 1,059,600

Earnout liability


Settlement of accounts receivable and net contract liabilities
(94,980 )

  $ 964,620


The settlement of accounts receivable and net contract liabilities represents amounts effectively settled upon the purchase of Echo, which originated from contacts between the Company and Echo prior to the purchase date. 


The following table summarizes the preliminary allocation of the purchase price to the assets acquired and liabilities assumed for the Echo Acquisition:  

 

19


SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)

 

9.

Business Combination (continued)



Cash and cash equivalents 

$

316,432



Accounts receivable

 

 252,557



Inventories

 

130,799



Prepaid expenses and other current assets 

 

7,400



Property, plant and equipment

 

1,154,818



Right-of-use assets

 

57,120



Goodwill
85,810

Intangible assets

 

68,344



Accounts payable and accrued expenses 

 

(733,529

)

Assumed liabilities
(285,204 )

Contract liabilities

 

(32,807

)

Lease liability

 

(57,120

)

 

$

964,620


 

As part of the Echo Acquisition, the Company recorded a contingent consideration liability for additional payments due to the sellers of Echo. These payments are due in accordance with the APA and are based upon the net income obtained from the Echo business during certain earnout periods. The initial contingent consideration liability of $0 was based on the fair value of the contingent consideration liability at the acquisition date, and is payable in cash and shares of restricted common stock of the Company. As of March 31, 2021, the liability remains to be $0.

 

10.

Leases

 

The Company leases an office, a manufacturing plant and certain equipment under non-cancelable operating lease agreements. The leases have remaining lease terms of two and a half years to five years. The plant lease includes an option to extend the lease for up to five years. In addition, CAT leases a vacant retail space that has been converted for the use of COVID-19 testing, vaccine distribution and a medical lab. The CAT lease term is for eighteen months.

 Supplemental balance sheet information related to leases is as follows:   


Balance Sheet Location
March 31, 2021


Operating Leases




Right-of-use assets, net
$ 1,538,885







Current liabilities Lease liability, current maturities 

(413,084

)

Non-current liabilities Lease liability, net of current maturities
(1,126,283 )

Total operating lease liabilities
$ (1,539,367 )







Finance Leases




Right-of-use assets
$ 46,653







Current liabilities Lease liability, current maturities
(19,059 )

Non-current liabilities Lease liability, net of current maturities 
(26,318 )

Total finance lease liabilities 
$ (45,377 )







Weighted Average Remaining Lease Term






Operating leases

4.15 years

Finance leases

2.36 years

Weighted Average Discount Rate 





Operating leases

3%

Finance leases

3%


20


SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)

 

10.

Leases (continued)


As the leases do not provide an implicit rate, the Company used an incremental borrowing rate based on the information available at the lease commencement date in determining the present value of the lease payments, which is reflective of the specific term of the leases and economic environment of each geographic region. 


Anticipated future lease costs, which are based in part on certain assumptions to approximate minimum annual rental commitments under non-cancelable leases, are as follows: 

 


Year Ending December 31,  

Operating

Financing

Total

2021
$ 340,209
$ 15,120
$ 355,329

2022

401,622

20,160

421,782

2023

330,300

11,760

342,060

2024

324,000

-

324,000

2025

243,000

-

243,000

Total lease payments

1,639,131

47,040

1,686,171

Less: Imputed interest

99,764

1,663

101,427

Present value of lease liabilities
$ 1,539,367
$ 45,377
$ 1,584,744

 

CAT has subleased its leased vacant area for a period of one year, the licensee has the option to terminate at any time after the first six month. Anticipated future lease revenue, under this leases is $1,440,000 for the remaining period ending December 31, 2021 and $320,000 for the year ending December 31, 2022.


 

11.

Net Income (Loss) Per Share


Basic net income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per share is computed by dividing the net income (loss) for the period by the weighted average number of common and potentially dilutive common shares outstanding during the period. Potentially dilutive common shares consist of the common shares issuable upon the exercise of stock options and warrants. Potentially dilutive common shares are excluded from the calculation if their effect is antidilutive. 

  

At March 31, 2021, there were options, including options granted to non-employees and non-directors, restricted stock units and warrants to purchase 36,436, 884,343 and 128,090 shares of common stock, respectively, outstanding that could potentially dilute future net income per share. Because the Company had a net loss as of March 31, 2021, it is prohibited from including potential common shares in the computation of diluted per share amounts. Accordingly, the Company has used the same number of shares outstanding to calculate both the basic and diluted loss per share. At March 31, 2020, there were options, including options to non-employees and non-directors, restricted stock units and warrants to purchase 52,337, 9,187 and 53,190 shares of common stock, respectively, outstanding that could potentially dilute future net income per share.

 

12.

Construction Backlog

 

The following represents the backlog of signed construction and engineering contracts in existence at March 31, 2021 and December 31, 2020, which represents the amount of revenue the Company expects to realize from work to be performed on uncompleted contracts in progress and from contractual agreements in effect at March 31, 2021 and December 31, 2020, respectively, on which work has not yet begun:


21


SG BLOCKS, INC. AND SUBSIDIARIES


Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)


12.

Construction Backlog (continued)


 

 

 

2021

 

 

2020

 

 

Balance - beginning of period

 

$

25,117,461

 

 

$

17,634,261

 

 

New contracts and change orders during the period

 

 

1,047,324

 

 

 

13,816,785

 


Adjustments and cancellations, net



(27,370 )

 

Subtotal  

 

 

26,164,785

 

 

 

31,423,676

 

 

Less: contract revenue earned during the period

 

 

(3,293,305

)

 

 

(6,306,215

)

 

Balance - end of period

 

$

22,871,480

 

 

$

25,117,461

 

 

Backlog at March 31, 2021 included two contracts entered into during the third quarter of 2020 in the amount of approximately $4 million and approximately $2.95 million along with three contracts during the fourth quarter of 2020 in the amount of approximately $2.7 million, $0.80 million, and $0.70 million. In addition, the Company executed one large contract in the first quarter of 2021 in the amount of approximately $1.3 million. The Company expects that all of this revenue will be realized by March 31, 2023. Under the ELA, the Company cannot guarantee, but expects to receive, approximately $2.4 million in royalties for one such project. The Company expects to receive these royalties for this one such project through September 30, 2022. Backlog does not include expected royalty fees to the Company under the ELA from projects to be delivered by our licensee. 

   

The Company’s remaining backlog as of March 31, 2021 represents the remaining transaction price of firm contracts for which work has not been performed and excludes unexercised contract options. 


The Company expects to satisfy its backlog which represents the remaining unsatisfied performance obligation on contracts as of March 31, 2021 over the following period:





2021

Within 1 year
$ 10,015,230

1 to 2 years


12,856,250

Total Backlog
$ 22,871,480


Although backlog reflects business that is considered to be firm, cancellations, deferrals or scope adjustments may occur. Backlog is adjusted to reflect any known project cancellations, revisions to project scope and cost and project deferrals, as appropriate.


22


SG BLOCKS, INC. AND SUBSIDIARIES


Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)


13.

Stockholders’ Equity 

 

Public Offerings –


In April 2020, the Company also completed a public offering of its common stock (the "April Public Offering"). In connection with the April Public Offering, the Company sold 440,000 shares of common stock at a public offering price of $4.25 per share, resulting in aggregate net proceeds of approximately $1,522,339 after deducting underwriting discounts and commissions and other expenses related to the offering. The Company incurred a total of approximately $347,661 in issuance costs in connection with the offering and no warrants to purchase were issued to the underwriters. 


In May 2020, the Company completed a public offering of its common stock (the "May Public Offering"). In connection with the May Public Offering, the Company sold 6,000,000 shares of common stock at a public offering price of $2.50 per share. Pursuant to the terms of the related Underwriting Agreement dated May 6, 2020 by and among the Company and ThinkEquity, a division of Fordham Financial Management, Inc., as representatives of several underwriters named therein ("ThinkEquity"), ThinkEquity was granted an over-allotment option to purchase up to an additional 900,000 shares of the Company's common stock, par value $0.01 per share (the "Common Stock"), in connection with the previously announced public offering. On May 15, 2020, ThinkEquity exercised in full such option with respect to all 900,000 shares of the Company's Common Stock (the "Option Shares"). After giving effect to the full exercise of the over-allotment option, the total number of shares of Common Stock sold by the Company in the May Public Offering was 6,900,000 shares of Common Stock and total net proceeds to the Company, after deducting underwriting discounts and commissions and other offering expenses payable by the Company, were approximately $15,596,141. The Company incurred a total of approximately $1,653,859 in issuance costs in connection with the offering and issued warrants to purchase 300,000 shares of common stock to the underwriters.


23


SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)



14.

Warrants  

 

In conjunction with the June 2017 Public Offering, the Company issued to certain affiliates of the underwriters, as compensation, warrants to purchase an aggregate of 4,313 shares of common stock at an exercise price of $125.00 per share. The warrants are exercisable at the option of the holder on or after June 21, 2018 and expire June 21, 2023.The fair value of warrants was calculated utilizing a Black-Scholes model and amounted to $63,796. The fair market value of the warrants as of the date of issuance has been included in issuance costs in additional paid-in capital.


In conjunction with the Purchase Agreement in April 2019, the Company also sold warrants to purchase up to an aggregate of 42,388 shares of common stock at an initial exercise price of $27.50 per share. The warrants are exercisable at the option of the holder on or after October 29, 2019 and expire October 29, 2024. The Company issued to certain affiliates of the underwriters, as compensation, warrants to purchase an aggregate of 4,239 shares of common stock at an initial exercise price of $27.50 per share. The warrants are exercisable at the option of the holder on or after October 29, 2019 and expire April 24, 2024.


In conjunction with the Underwriting Agreement in August 2019, the Company issued to the underwriter, as compensation, warrants to purchase an aggregate of 2,250 shares of common stock at an initial exercise price of $21.25 per share. The warrants are exercisable at the option of the holder on or after February 1, 2020 and expire August 29, 2024


In conjunction with the Underwriting Agreement in May 2020, the Company issued to the underwriter, as compensation, warrants to purchase an aggregate of 300,000 shares of common stock at an initial exercise price of $3.14 per share. The warrants are exercisable at the option of the holder on or after November 6, 2020 and expire May 5, 2025.  During the three months ended March 31, 2021, 225,100 warrants were exercised and converted into common stock of the Company.  The Company received proceeds of approximately $703,000 from the conversion of the exercised warrants. 


In connection with a convertible debenture issued on November 12, 2019, the Company entered into a Placement Agency Agreement (the “Placement Agency Agreement”) with ThinkEquity, a division of Fordham Financial Management, Inc. (the “Placement Agent”), pursuant to which the Company had agreed to pay the Placement Agent a cash fee equal to 9% of the gross proceeds received by the Company from the investor in this transaction, as well as a one-time expense fee of $15,000 for aggregate out-of-pocket expenses incurred collectively in this transaction. Pursuant to the Placement Agency Agreement, the Company also agreed to grant to the Placement Agent or its designees warrants to purchase up to 9% of the aggregate number of shares of common stock underlying the Debenture, which was equal to 5,404 shares of common stock, at an exercise price of 110% of the closing price of the Company’s common stock on the closing date (the “Placement Agent Warrants”).

 

The Placement Agent Warrants were exercisable, in whole or in part, commencing on the issuance date and have an exercise period of five years. In the event that there is not an effective registration statement permitting for the resale of the shares underlying the Placement Agent Warrants, the Placement Agent Warrant’s shall be exercisable on a cashless basis. There are significant restrictions pursuant to FINRA Rule 5110 against transferring the Placement Agent’s Warrants and the shares issuable upon exercise of the Placement Agent Warrants during the one hundred eighty (180) days after the closing date. 

 

On December 10, 2019, the Company and ThinkEquity entered into a waiver agreement (“Waiver of Warrant”) pursuant to which ThinkEquity surrendered its rights to a warrant previously issued to ThinkEquity on November 12, 2019 to purchase 5,404 shares of the Company’s common stock as compensation for acting as placement agent for the private placement of the Debenture. For the three months ending March 31, 2021, we had 225,100 warrants that converted into common stock.


24


 SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)

 

15.

Share-based Compensation  


On October 26, 2016, the Company’s Board of Directors approved the issuance of up to 25,000 shares of the Company’s common stock in the form of restricted stock or options (“2016 Stock Plan”). Effective January 20, 2017, the 2016 Stock Plan was amended and restated as the SG Blocks, Inc. Stock Incentive Plan, as further amended effective June 1, 2018 and as further amended on July 30, 2020 (the “Incentive Plan”). The Incentive Plan authorizes the issuance of up to 1,125,000 shares of common stock. It authorizes the issuance of equity-based awards in the form of stock options, stock appreciation rights, restricted shares, restricted share units, other share-based awards and cash-based awards to non-employee directors and to officers, employees and consultants of the Company and its subsidiary, except that incentive stock options may only be granted to the Company’s employees and its subsidiary’s employees. The Incentive Plan expires on October 26, 2026, and is administered by the Company’s Compensation Committee of the Board of Directors. Each of the Company’s employees, directors, and consultants are eligible to participate in the Incentive Plan. As of March 31, 2021, there were 179,547 shares of common stock available for issuance under the Incentive Plan


Stock-Based Compensation Expense   


Stock-based compensation expense is included in the condensed consolidated statements of operations as follows:   






Three Months Ended
March 31,





2021
2020


Payroll and related expenses

   


$

286,186

   

$

38,764

   

 

       Total

   


$

286,186

   

$

38,764

   

 

The following table presents total stock-based compensation expense by security type included in the condensed consolidated statements of operations:  






Three Months Ended
March 31,





 2021

2020

 

Stock options

   


$

2,666

  

  

$

2,667

   

 

Restricted Stock Units 

   


 

283,520

  

  

 

36,097

   


Total

$ 286,186

$ 38,764


Stock-Based Option Awards 


The Company has issued no stock-based options during the three months ended March 31, 2021 and 2020.   

 

 

25


SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)

 

15.

Share-based Compensation (continued)


Because the Company does not have significant historical data on employee exercise behavior, the Company uses the “Simplified Method” to calculate the expected life of the stock-based option awards granted to employees. The simplified method is calculated by averaging the vesting period and contractual term of the options.  


The following table summarizes stock-based option activities and changes during the three months ended March 31, 2021 as described below:

 


 

 

 Shares

 

 

Weighted Average Fair Value Per Share

 

 

Weighted
Average Exercise Price Per Share

 

 

Weighted Average Remaining Terms (in years)

 

 

Aggregate Intrinsic Value

 


Outstanding – December 31, 2020

 

 

36,437

 

 

$

35.54

 

 

$

78.71

 

 

 

6.34

 

 

$

 


Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Exercised 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Cancelled

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Outstanding – March 31, 2021

 

 

36,437

 

 

 

24.80

 

 

 

78.71

 

 

 

6.09

 

 

$

 


Exercisable – December 31, 2020

 

 

36,332

 

 

 

24.80

 

 

 

78.67

 

 

 

6.34

 

 

 

 


Exercisable – March 31, 2021

 

 

36,437

 

 

$

24.80

 

 

$

78.71

 

 

 

6.09

 

 

$

 

  

For the three months ended March 31, 2021 and 2020, the Company recognized stock-based compensation expense of $2,666 and $2,667, respectively, related to stock options. This expense is included in payroll and related expenses, in the accompanying condensed consolidated statements of operations.  

 

As of March 31, 2021, there was no unrecognized compensation costs related to non-vested stock options and all options have been expensed. The intrinsic value is calculated as the difference between the fair value of the stock price at year end and the exercise price of each of the outstanding stock options. The fair value of the stock price at March 31, 2021 was $4.66 per share.


Restricted Stock Units 


On March 22, 2019, a total of 15,703 of restricted stock units were granted to Mr. Galvin, Mr. Armstrong, Mr. Shetty, six employees and one consultant of the Company, under the Company's stock-based compensation plan, at the fair value of $54.00 per share, which represents the closing price of the Company's common stock on February 26, 2019, as adjusted for stock splits. Restricted stock units granted to Mr. Galvin, Mr. Armstrong, Mr. Shetty, and an aggregate of six employees and one consultant of 6,139, 772, 5,729 and an aggregate of 3,063, respectively, vest in installments over either a one-year, two-year, three-year and four-year period and will fully vest by the end of December 31, 2022. The fair value of these units upon issuance amounted to $847,957. 


On January 15, 2019 and February 26, 2019, a total of 526 of restricted stock units were granted to two of the Company’s non-employee directors, under the Incentive Plan, at the calculated fair value of $58.80 and $55.20 per share, respectively, which represents the average closing price of the Company’s common stock for the ten trading days immediately preceding and including the grant date, as adjusted for stock splits.  The restricted stock units granted on January 15, 2019 vested on January 15, 2020, subject to each individual’s continued service as a director of the Company through such date, and are payable six months after the termination of the director from the Company’s Board of Directors or death or disability. The restricted stock units granted on February 26, 2019 vested on the earlier of (A) the first anniversary of the date of the grant or (B) the date of the 2019 annual meeting of the Company’s stockholders subject to each individual’s continued service as a director of the Company through such date, and are payable six months after the termination of the director from the Board of Directors or death or disability.


Effective June 5, 2019, a total of 9,189 of restricted stock units were granted to the Company’s non-employee directors, under the Company’s stock-based compensation plan, at the calculated fair value of $16.40 per share, which represents the average closing price of the Company’s common stock for the ten trading days immediately preceding and including the grant date. Restricted stock units granted to directors on June 5, 2019 vest on the earlier of (A) the first anniversary of the date of the grant or (B) the date of the annual meeting of the Company’s stockholders that occurs in the year immediately following the date of the grant; and are payable six months after the termination of the director from the Board or death or disability.



26


SG BLOCKS, INC. AND SUBSIDIARIES

 

Notes to Condensed Consolidated Financial Statements

For the Three Months Ended March 31, 2021 and 2020 (Unaudited)

 

15.

Share-based Compensation (continued)


On April 14, 2020, a total of 35,331 of restricted stock units were granted to Mr. Galvin, Mr. Armstrong, Mr. Sheeran, five employees and two consultants of the Company, under the Company's stock-based compensation plan, at the fair value of $4.76 per share, which represents the closing price of the Company's common stock on April 14, 2020. Restricted stock units granted to Mr. Galvin, Mr. Armstrong, Mr. Sheeran, and an aggregate of five employees and one consultant of 11,331, 1,000, 3,000 and an aggregate of 8,000, respectively, will vest in full on the first anniversary of the vesting commencement date and one consultant received 12,000 restricted stock units that vested immediately on April 15, 2020. The fair value of these units upon issuance amounted to $168,176. 


On April 14, 2020, a total of 12,000 of restricted stock units were granted to three of the Company’s non-employee directors, under the Incentive Plan, at the calculated fair value of $4.76 per share, which represents the closing price of the Company’s common stock on April 14, 2020. The restricted stock units granted on April 14, 2020 will fully vest on April 14, 2021, subject to each individual’s continued service as a director of the Company through such date, and are payable six months after the termination of the director from the Company’s Board of Directors or death or disability. The fair value of these units upon issuance amounted to $57,120. 


On September 23, 2020, a total of 425,000 of restricted stock units were granted to Mr. Armstrong, Mr. Sheeran, seven employees and one consultant of the Company, under the Company's stock-based compensation plan, at the fair value of $1.81 per share, which represents the closing price of the Company's common stock on September 23, 2020. Restricted stock units granted to Mr. Armstrong, Mr. Sheeran, and an aggregate of seven employees and one consultant of 50,000, 75,000 and an aggregate of 300,000, respectively, and 1/3 will vest on September 23, 2020, 1/3 on the one year anniversary of the grant date and 1/3 on the two year anniversary of the grant date. The fair value of these units upon issuance amounted to $769,250.  


On November 11, 2020, a total of 46,826 of restricted stock units were granted to three of the Company’s non-employee directors, under the Incentive Plan, at the calculated fair value of $2.39 per share, which represents the closing price of the Company’s common stock on November 11, 2020. The restricted stock units granted on November 11, 2020 will vest 1/2 on November 11, 2020 and 1/2 on the one year anniversary of the grant date, subject to each individual’s continued service as a director of the Company through such date, and are payable six months after the termination of the director from the Company’s Board of Directors or death or disability. The fair value of these units upon issuance amounted to $111,920.